๋ํํ๋๋ผ๋ฏผ
๋ํํ๋๋ผ๋ฏผ์ ์์ํ์์ ๋๋ฆฌ ์ฌ์ฉ๋๋ **1์ธ๋ ์ํ์ฌ์๋ฏผ๊ณ ํญํ์คํ๋ฏผ์ **์ ๋๋ค. * **์ฃผ์ ์ ์์ฆ**: ์๋ ๋ฅด๊ธฐ ๋ฐ์(๋๋๋ฌ๊ธฐ, ํ๊ด๋ถ์ข , ์ํ ํผ), ์์์ฆ ๋ฐ ์๋ํ๋ฝ์์ค ๊ด๋ฆฌ. * **์ด์ฐจ ์ ์์ฆ**: ๋ฉ๋ฏธ ์๋ฐฉ, ๊ฐ๋ฒผ์ด ์ง์ ๋ฐ ํญ๊ตฌํ ์ . **์์ ์์ **: * ํ์ก๋์ฅ๋ฒฝ(BBB)์ ์ฝ๊ฒ ํต๊ณผํ๊ธฐ ๋๋ฌธ์ 2์ธ๋ ํญํ์คํ๋ฏผ์ (์: ์ธํฐ๋ฆฌ์ง, ๋ก๋ผํ๋)์ ๋นํด ๋ ๋๋ ทํ ์ค์ถ์ ๊ฒฝ๊ณ ์ต์ (์ง์ ) ์์ฉ์ ์ผ์ผํต๋๋ค. * ๊ณ ์์ด์ ๊ฒฝ์ฐ ํ์คํ๋ฏผ์ด ๊ตฌํ ๋ฅผ ์ ๋ฐํ๋ ์ฃผ์ ๋งค๊ฐ์ฒด๋ก ๊ฐ์ฃผ๋์ง ์์ต๋๋ค. ๋ฐ๋ผ์ ๊ณ ์์ด์ ๋ฉ๋ฏธ๋ ๊ตฌํ ๋ฅผ ์น๋ฃํ ๋๋ ๋ํํ๋๋ผ๋ฏผ๋ณด๋ค NK-1 ๊ธธํญ์ (์: ๋ง๋กํผํดํธ)๋ M1-์ฝ๋ฆฐ์ฑ ๊ธธํญ์ ๊ฐ ์ผ๋ฐ์ ์ผ๋ก ๋ ์ ํธ๋ฉ๋๋ค. * ์์ ๋ฌด๊ท ์ฑ ์ ์ฝ์ผ ๋ฐ ๊ณ ์์ด ์ท์ฅ์ผ์ ๋ณด์กฐ ์น๋ฃ์ ๋ก ์ฌ์ฉ๋๊ธฐ๋ ํฉ๋๋ค.
์์ฉ ๊ธฐ์ : Diphenhydramine exerts its effects through multiple pathways: * **H1-Receptor Antagonism**: Competitively binds to and blocks **H1 receptors** on effector cells โ prevents histamine-mediated capillary permeability, vasodilation, and smooth muscle spasms (bronchoconstriction). * **Central Effects**: Readily crosses the blood-brain barrier โ blocks central **H1 receptors** โ produces sedation and antiemetic effects. * **Anticholinergic Activity**: Non-selectively binds to **muscarinic receptors** โ decreases exocrine secretions (drying effect) and can cause urinary retention or tachycardia. * **Additional Effects**: Possesses mild antitussive properties.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- As an antihistamine ยท 0.5 mg/kg ยท PO ยท q12h ยท Liquid formulation is distasteful
- As an antihistamine ยท 2-4 mg (total dose) ยท PO ยท q12-24h
- As an antihistamine ยท 2-4 mg/kg ยท PO ยท q8h
- For severe urticaria and angioedema ยท 2 mg/kg ยท IM ยท twice daily as needed ยท Used with steroids (prednisone 2 mg/kg IM twice daily) and epinephrine 1:10,000 (0.5-2 mL SC)
- For adjunctive treatment of pancreatitis ยท 2-4 mg/kg ยท PO ยท q8h
- Prevaccination ยท 2 mg/kg ยท PO, IM or IV ยท 10 minutes prior to vaccination
- Pretreatment before doxorubicin ยท 5 mg (total dose) ยท IM ยท Single dose
- For adjunctive therapy of anaphylaxis ยท 0.5-1 mg/kg ยท IM or IV ยท Single dose ยท Used with epinephrine and steroids
- For adjunctive therapy of aseptic laminitis ยท 55-110 mg/100 kg body weight (0.55-1.1 mg/kg) ยท IV or IM ยท Single dose ยท During the acute phase ยท Used with corticosteroids
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Hypersensitivity to diphenhydramine or other antihistamines in its class
- Angle closure glaucoma
- Prostatic hypertrophy
- Pyloroduodenal or bladder neck obstruction
- COPD (if mucosal secretions are a problem)
- Hyperthyroidism (use with caution)
- Cardiovascular disease or hypertension (use with caution)
- Seizure disorders (use with caution)
- Known hypersensitivity to diphenhydramine
- Glaucoma (due to anticholinergic effects)
- Prostatic hypertrophy or urinary retention
- Gastrointestinal obstruction
- Use with caution in working dogs due to sedation
์ด์๋ฐ์
- CNS depression (lethargy, somnolence)
- Anticholinergic effects (dry mouth, urinary retention)
- GI effects (diarrhea, vomiting, anorexia)
- Paradoxical excitement (especially in cats)
- Sedation/lethargy
- Dry mouth (xerostomia)
- Urinary retention
- Tachycardia
- Gastrointestinal disturbances (diarrhea, vomiting, anorexia)
์ฝ๋ฌผ ์ํธ์์ฉ
- Anticholinergic drugs (including tricyclic antidepressants) ยท May potentiate anticholinergic effects
- CNS depressant drugs ยท Increased sedation can occur
- CNS Depressants (e.g., opioids, benzodiazepines, barbiturates) ยท Additive sedation and central nervous system depression ยท moderate
- Anticholinergic drugs ยท Additive anticholinergic effects (dry mouth, tachycardia, urinary retention) ยท moderate
- Monoamine Oxidase Inhibitors (MAOIs) ยท May prolong and intensify the anticholinergic effects of antihistamines ยท major
- CNS Depressants (e.g., Diazepam, Phenobarbital, Gabapentin) ยท Additive CNS depression and sedation ยท moderate
- Anticholinergic drugs (e.g., Atropine, Glycopyrrolate) ยท Additive anticholinergic effects (tachycardia, dry mouth, ileus) ยท moderate
- Tricyclic Antidepressants (e.g., Amitriptyline) ยท Increased risk of anticholinergic toxicity and sedation ยท moderate
๋ชจ๋ํฐ๋ง
- Clinical efficacy (reduction in pruritus, allergic signs, or vomiting)
- Adverse effects (excessive sedation, anticholinergic signs)
- Resolution of allergic signs or pruritus
- Degree of sedation
- Heart rate (monitor for tachycardia)
- Urination frequency (monitor for retention)
๊ณผ์ฉ๋
Overdosage can cause **CNS stimulation** (ranging from excitement to seizures) or **CNS depression** (lethargy to coma), severe anticholinergic effects, respiratory depression, and death. **Treatment**: * Empty the gut after oral ingestion using standard protocols. * Induce emesis if the patient is alert and CNS status is stable. * Administer a saline cathartic and/or activated charcoal after emesis or gastric lavage. * Provide symptomatic and supportive therapies. * **Seizure management**: Phenytoin (IV) is recommended in humans for seizures caused by antihistamine overdose; **barbiturates and diazepam should be avoided**.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.